Showing 1 - 20 results of 24 for search 'Stijn L W Koolen', query time: 1.02s
Refine Results
-
1
-
2
-
3
-
4
-
5
Development of [<sup>225</sup>Ac]Ac-PSMA-I&T for Targeted Alpha Therapy According to GMP Guidelines for Treatment of mCRPC by Eline L. Hooijman, Yozlem Chalashkan, Sui Wai Ling, Figen F. Kahyargil, Marcel Segbers, Frank Bruchertseifer, Alfred Morgenstern, Yann Seimbille, Stijn L. W. Koolen, Tessa Brabander, Erik de Blois
Published 2021-05-01
Article -
6
-
7
The Influence of Body Composition on the Systemic Exposure of Paclitaxel in Esophageal Cancer Patients by Leni van Doorn, Marie-Rose B. S. Crombag, Hánah N. Rier, Jeroen L. A. van Vugt, Charlotte van Kesteren, Sander Bins, Ron H. J. Mathijssen, Mark-David Levin, Stijn L. W. Koolen
Published 2021-01-01
Article -
8
Combining Sorafenib and Immunosuppression in Liver Transplant Recipients with Hepatocellular Carcinoma by Koen G. A. M. Hussaarts, Leni van Doorn, Sander Bins, Dave Sprengers, Peter de Bruijn, Roelof W. F. van Leeuwen, Stijn L. W. Koolen, Teun van Gelder, Ron H. J. Mathijssen
Published 2021-01-01
Article -
9
Toward model-informed precision dosing for tamoxifen: A population-pharmacokinetic model with a continuous CYP2D6 activity scale by Bram C. Agema, Sanne M. Buijs, Sebastiaan D.T. Sassen, Thomas E. Mürdter, Mathias Schwab, Birgit C.P. Koch, Agnes Jager, Ron H.N. van Schaik, Ron H.J. Mathijssen, Stijn L.W. Koolen
Published 2023-04-01
Article -
10
In Vivo Efficacy Testing of Peptide Receptor Radionuclide Therapy Radiosensitization Using Olaparib by Danny Feijtel, Thom G. A. Reuvers, Christine van Tuyll-van Serooskerken, Corrina M. A. de Ridder, Debra C. Stuurman, Erik de Blois, Nicole S. Verkaik, Peter de Bruijn, Stijn L. W. Koolen, Marion de Jong, Julie Nonnekens
Published 2023-02-01
Article -
11
Influence of Genetic Variation in <i>COMT</i> on Cisplatin-Induced Nephrotoxicity in Cancer Patients by Bram C. Agema, Stijn L.W. Koolen, Mirjam de With, Nadia van Doorn, Niels Heersche, Esther Oomen-de Hoop, Sabine Visser, Joachim G.J.V. Aerts, Sander Bins, Ron H.N. van Schaik, Ron H.J. Mathijssen
Published 2020-03-01
Article -
12
Radiolabeling and quality control of therapeutic radiopharmaceuticals: optimization, clinical implementation and comparison of radio-TLC/HPLC analysis, demonstrated by [177Lu]Lu-PS... by Eline L. Hooijman, Carolline M. Ntihabose, Thom G. A. Reuvers, Julie Nonnekens, Else A. Aalbersberg, Jordy R. J. P. van de Merbel, Judith E. Huijmans, Stijn L. W. Koolen, Jeroen J. M. A. Hendrikx, Erik de Blois
Published 2022-11-01
Article -
13
Docetaxel Skin Exposure and Micronucleation Contributes to Skin Toxicity Caused by CPC634 by Florence Atrafi, Ruben A. G. van Eerden, Stijn L. W. Koolen, Peter de Bruijn, Cristianne J. F. Rijcken, Rob Hanssen, Ferry A. L. M. Eskens, Martijn P. Lolkema, Esther Oomen-de Hoop, Jeffrey Damman, Ron H. J. Mathijssen
Published 2021-07-01
Article -
14
Pharmacokinetics of Sublingually Delivered Fentanyl in Head and Neck Cancer Patients Treated with Curatively Aimed Chemo or Bioradiotherapy by Evelien J. M. Kuip, Wendy H. Oldenmenger, Esther Oomen-de Hoop, Gerda M. Verduijn, Martine F. Thijs-Visser, Peter de Bruijn, Esther van Meerten, Stijn L. W. Koolen, Ron H. J. Mathijssen, Carin C. D. van der Rijt
Published 2018-11-01
Article -
15
Effect of Scalp Cooling on the Pharmacokinetics of Paclitaxel by Leni van Doorn, Mandy M. van Rosmalen, Wendy M. van der Deure, Esther Oomen-de Hoop, Robert Porrazzo, Sophie M. Wijngaard, Ingrid A. Boere, Paola Veenstra, Eman Ibrahim, Peter de Bruijn, Lena E. Friberg, Stijn L. W. Koolen, Ron H. J. Mathijssen, Agnes Jager
Published 2021-08-01
Article -
16
A common germline variant in CYP11B1 is associated with adverse clinical outcome of treatment with abiraterone or enzalutamide by Stefan A.J. Buck, Marinda Meertens, Frederiek M.F. van Ooijen, Esther Oomen-de Hoop, Evert de Jonge, Marieke J.H. Coenen, Andries M. Bergman, Stijn L.W. Koolen, Ronald de Wit, Alwin D.R. Huitema, Ron H.N. van Schaik, Ron H.J. Mathijssen
Published 2023-12-01
Article -
17
The interplay between tamoxifen and endoxifen plasma concentrations and coagulation parameters in patients with primary breast cancer by Sanne M. Buijs, Daan C.H. van Dorst, Marieke J.H.A. Kruip, Rob F.P. van den Akker, Ka L. Cheung, Robert Porrazzo, Esther Oomen-de Hoop, Agnes Jager, Stijn L.W. Koolen, Jorie Versmissen, A.H. Jan Danser, Henri H. Versteeg, Mettine H.A. Bos, Ron H.J. Mathijssen
Published 2024-01-01
Article -
18
Hepatotoxicity in patients with non-small cell lung cancer treated with sotorasib after prior immunotherapy: a comprehensive clinical and pharmacokinetic analysisResearch in contex... by Sophie M. Ernst, Maaike M. Hofman, Tessa E. van der Horst, Marthe S. Paats, Frank W.J. Heijboer, Joachim G.J.V. Aerts, Daphne W. Dumoulin, Robin Cornelissen, Jan H. von der Thüsen, Peter de Bruijn, Esther Oomen-de Hoop, Ron H.J. Mathijssen, Stijn L.W. Koolen, Anne-Marie C. Dingemans
Published 2024-04-01
Article -
19
Influence of Probenecid on the Pharmacokinetics and Pharmacodynamics of Sorafenib by Koen G. A. M. Hussaarts, Leni van Doorn, Karel Eechoute, Jeffrey Damman, Qiang Fu, Nadia van Doorn, Eric D. Eisenmann, Alice A. Gibson, Esther Oomen-de Hoop, Peter de Bruijn, Sharyn D. Baker, Stijn L. W. Koolen, Teun van Gelder, Roelof W. F. van Leeuwen, Ron H. J. Mathijssen, Alex Sparreboom, Sander Bins
Published 2020-08-01
Article -
20
Systemic exposure of floxuridine after hepatic arterial infusion pump chemotherapy with floxuridine in patients with resected colorectal liver metastases by Nikki S. IJzerman, Wills F. Filipe, Peter de Bruijn, Florian E. Buisman, Leni van Doorn, Pascal G. Doornebosch, Jessica J. Holster, Cecile Grootscholten, Dirk J. Grünhagen, Christian P.E. van Bommel, Marjolein Y.V. Homs, Niels F.M. Kok, Cornelis Verhoef, Bas Groot Koerkamp, Koert F.D. Kuhlmann, Ron H.J. Mathijssen, Stijn L.W. Koolen
Published 2023-06-01
Article